2023-07-19T00:51:07Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:07Z
ENA-LAST-UPDATE
SAMN31739615
External Id
GSM6732488
External Id
2023-07-19T00:51:07Z
INSDC first public
2023-07-19T00:51:07Z
INSDC last update
public
INSDC status
SRS15765448
SRA accession
GSM6732488
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD4+
cell type
H3 pan-acetyl
chip antibody
missing
collection_date
human
common name
1
dataset
male
gender
missing
geo_loc_name
36.97%
infusion percent_cd4
57.07%
infusion percent_cd8
3.40E+10
number til_infused
Homo sapiens
organism
4
overall survival_months
1
pfs censor_at_12_months
3
pfs months
PD
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
1
survival censor
TIL ACT Product
tissue
Patient 1 CD4+ [Pt01_CD4]
title
TIL ACT
treatment
15781
trial